All are true regarding treatment of Guillain-Barre syndrome, EXCEPT:: (A) Coicosteroid are used for early recovery and to prevent complications, (B) High-dose intravenous immune globulin can be initiated, (C) Plasmapheresis can be indicated, (D) High-dose intravenous immune globulin and plasmapheresis are equally effective
Answer is A. In the vast majority of patients with GBS, treatment should be initiated as soon after diagnosis as possible. 2 weeks after the first motor symptoms, immunotherapy is no longer effective. Either high-dose intravenous immune globulin (IVIg) or plasmapheresis can be initiated, as they are equally effective. A combination of the two therapies is not significantly better than either alone. Glucocoicoid administration does not shoen the course or prognosis of GBS.